• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Thoratec Corp

+ Add to Watchlist


26.7300 USD 0.6750 2.46%

As of 16:30:00 ET on 09/30/2014.

Snapshot for Thoratec Corp (THOR)

Open: 27.3200 Day's Range: 26.7300 - 27.4700 Volume: 1,070,771
Previous Close: 27.4050 52wk Range: 22.5000 - 43.5800 1-Yr Rtn: -28.32%

Stock Chart for THOR

No chart data available.
  • THOR:US 26.7500
  • 1D
  • 1M
  • 1Y
Interactive THOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THOR

Current P/E Ratio (ttm) 20.6081
Estimated P/E(12/2014) 20.4082
Relative P/E vs. SPX 1.1371
Earnings Per Share (USD) (ttm) 1.3102
Est. EPS (USD) (12/2014) 1.3230
Est. PEG Ratio 2.3233
Market Cap (M USD) 1,520.10
Shares Outstanding (M) 56.30
30 Day Average Volume 1,011,435
Price/Book (mrq) 2.2234
Price/Sale (ttm) 3.0571
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THOR

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

D Keith GrossmanPresident/CEODavid A LehmanSenior VP/Secy/Gen Cnsl
Taylor C HarrisVP/CFOVasant PadmanabhanVP:Technical Operations
More Company Profile & Key Executives for THOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil